195 related articles for article (PubMed ID: 28560202)
1. Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran.
Eskandarieh S; Heydarpour P; Elhami SR; Sahraian MA
Iran J Public Health; 2017 May; 46(5):699-704. PubMed ID: 28560202
[TBL] [Abstract][Full Text] [Related]
2. Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999-2015.
Eskandarieh S; Allahabadi NS; Sadeghi M; Sahraian MA
BMC Neurol; 2018 Feb; 18(1):15. PubMed ID: 29415659
[TBL] [Abstract][Full Text] [Related]
3. A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.
Elhami SR; Mohammad K; Sahraian MA; Eftekhar H
Neuroepidemiology; 2011; 36(3):141-7. PubMed ID: 21508646
[TBL] [Abstract][Full Text] [Related]
4. Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.
Almasi-Hashiani A; Sahraian MA; Eskandarieh S
BMC Neurol; 2020 May; 20(1):169. PubMed ID: 32359352
[TBL] [Abstract][Full Text] [Related]
5. Multiple Sclerosis in Tehran: Rising Prevalence alongside Stabilizing Incidence - True Increase or Enhanced Diagnosis?
Mohebi F; Eskandarieh S; Mansournia MA; Mohajer B; Sahraian MA
Arch Iran Med; 2019 Aug; 22(8):429-434. PubMed ID: 31679345
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of familial multiple sclerosis: A population-based study in Tehran during 1999-2018.
Salehi Z; Almasi-Hashiani A; Sahraian MA; Eskandarieh S
Mult Scler Relat Disord; 2020 Aug; 43():102178. PubMed ID: 32417663
[TBL] [Abstract][Full Text] [Related]
7. Temporal Incidence and Prevalence Trends of Multiple Sclerosis in Markazi Province, Iran.
Faraji F; Ahmadi F; Mohaghegh P; Talaie A
Mult Scler Relat Disord; 2022 Apr; 60():103691. PubMed ID: 35217485
[TBL] [Abstract][Full Text] [Related]
8. The incidence and prevalence of crude and familial multiple sclerosis in Tehran, Iran in 2021.
Ezabadi SG; Ayoubi S; Sahraian MA; Omrani MA; Eskandarieh S
Neurol Sci; 2023 Dec; 44(12):4517-4518. PubMed ID: 37642789
[TBL] [Abstract][Full Text] [Related]
9. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.
Etemadifar M; Maghzi AH
Mult Scler; 2011 Aug; 17(8):1022-7. PubMed ID: 21459809
[TBL] [Abstract][Full Text] [Related]
10. Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: A case-control study.
Eskandarieh S; Nedjat S; Abdollahpour I; Moghadasi AN; Azimi AR; Sahraian MA
Mult Scler Relat Disord; 2017 Feb; 12():39-43. PubMed ID: 28283104
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time.
Sahraian MA; Khorramnia S; Ebrahim MM; Moinfar Z; Lotfi J; Pakdaman H
Eur Neurol; 2010; 64(6):331-6. PubMed ID: 21071949
[TBL] [Abstract][Full Text] [Related]
12. Spatial Analysis of Multiple Sclerosis Disease in Tehran Metropolitan Zone, Iran, 2001-2012.
Saei M; Holakouie-Naieni K; Mostafavi E; Sahraian MA; Mahmoodi M; Mansournia MA; Hosseini A
Iran J Public Health; 2014 May; 43(5):621-9. PubMed ID: 26060763
[TBL] [Abstract][Full Text] [Related]
13. Diffusion of interferon beta in Iran and its utilization in Tehran.
Palesh M; Jonsson PM; Jamshidi H; Wettermark B; Tomson G; Fredrikson S
Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):934-41. PubMed ID: 18509835
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series.
Amini P; Almasi-Hashiani A; Sahraian MA; Najafi M; Eskandarieh S
BMC Neurol; 2021 Jun; 21(1):235. PubMed ID: 34167483
[TBL] [Abstract][Full Text] [Related]
15. 18-year temporal trend of multiple sclerosis in southern Iran.
Mobasheri F; Fararouei M; Hasanzadeh J; Jaberi AR
Mult Scler Relat Disord; 2021 Jul; 52():103018. PubMed ID: 34023774
[TBL] [Abstract][Full Text] [Related]
16. Temporal trends of incidence and prevalence of multiple sclerosis in Razavi Khorasan Province, Northeast Iran.
Sarmadi M; Saravani H; Azizi O; Najafi F; Hadei M; Momeni J; Bazrafshan E
Neurol Sci; 2022 Jan; 43(1):583-591. PubMed ID: 33939041
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis in Isfahan, Iran.
Saadatnia M; Etemadifar M; Maghzi AH
Int Rev Neurobiol; 2007; 79():357-75. PubMed ID: 17531850
[TBL] [Abstract][Full Text] [Related]
18. Is the sharp increasing trend of multiple sclerosis incidence real in Iran?
Hosseinzadeh A; Sedighi B; Kermanchi J; Heidari M; Haghdoost AA
BMC Neurol; 2021 Jan; 21(1):7. PubMed ID: 33407243
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and Incidence of Multiple Sclerosis in Fars Province, Southern Iran.
Izadi S; Nikseresht AR; Poursadeghfard M; Borhanihaghighi A; Heydari ST
Iran J Med Sci; 2015 Sep; 40(5):390-5. PubMed ID: 26379344
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of multiple sclerosis in Isfahan, Iran.
Etemadifar M; Janghorbani M; Shaygannejad V; Ashtari F
Neuroepidemiology; 2006; 27(1):39-44. PubMed ID: 16804333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
